Purpose: Kenya is a large country with a widely dispersed population. As retinoblastoma requires specialized treatment, we determined the referral pattern for patients with retinoblastoma in Kenya to facilitate the formulation of a national policy.
Materials And Methods: A retrospective study was performed for retinoblastoma patients who presented from January 1, 2006 to December 31, 2007.
Background/aims: Clinical cancer genetics is an integral part of cancer control and management, yet its development as an essential medical service has been hindered in many low-and-middle-income countries. We report our experiences in developing a clinical cancer genetics service for retinoblastoma in Kenya.
Methods: A genetics task force was created from within the membership of the existing Kenyan National Retinoblastoma Strategy group.